Agoracom Blog Home

Author Archive

« Older Entries
Newer Entries »

PyroGenesis $PYR.ca Receives Confirmation that the first 5,000 TPY DROSRITE System Successfully Passes Factory Acceptance Test $RTN $NOC $UTX $DDD.ca $HPQ.ca

Posted by AGORACOM-JC at 4:42 PM on Thursday, November 19th, 2020
  • Further to its press release dated September 22 nd , 2020, PyroGenesis’ technology successfully passed the Factory Acceptance Test (“FAT”), conducted by Drosrite International LLC (“DI”), on behalf of their client, for the first 5,000 TPY DROSRITE™ System
  • The testing was held at DI’s supplier’s manufacturing facility, in the United States of America (“USA”), where the end user evaluated the equipment during, and after, the assembly process.
  • The end user verified that the 5,000 TPY DROSRITE™ System was manufactured and operated in accordance with, amongst other things, design specifications.
  • Based on this successful testing, the end user decided to forego performing an additional FAT test on the second 5,000 TPY DROSRITE™ System.
  • Both Systems are expected to be shipped from the USA to the Middle East, within the next four (4) weeks, and are expected to arrive approx. two (2) months thereafter.

MONTREAL, Nov. 19, 2020 — PyroGenesis Canada Inc. ( http://www.pyrogenesis.com ) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce that, further to its press release dated September 22 nd , 2020, PyroGenesis’ technology successfully passed the Factory Acceptance Test (“FAT”), conducted by Drosrite International LLC (“DI”), on behalf of their client, for the first 5,000 TPY DROSRITE™ System. 

“The success of this FAT testing marks an important milestone for PyroGenesis and DI,” said Mr. P. Peter Pascali, CEO and Chair of PyroGenesis. “Once again, we are proud to see the DROSRITE™ technology being adopted successfully, this time, for use in one of the premier aluminum smelters in the world. It indeed validates PyroGenesis’ DROSRITE™ technology, as it has become the dross processing solution of choice for an extremely discerning end-user. As one might expect, we have seen a significant increase in interest in our DROSRITE™ technology given that the DI contract, with its client, was awarded primarily based on the DROSRITE™ technology.”

The testing was held at DI’s supplier’s manufacturing facility, in the United States of America (“USA”), where the end user evaluated the equipment during, and after, the assembly process. The end user verified that the 5,000 TPY DROSRITE™ System was manufactured and operated in accordance with, amongst other things, design specifications. Based on this successful testing, the end user decided to forego performing an additional FAT test on the second 5,000 TPY DROSRITE™ System. Both Systems are expected to be shipped from the USA to the Middle East, within the next four (4) weeks, and are expected to arrive approx. two (2) months thereafter.

Before shipping, PyroGenesis is expected to receive an additional ~$2.6MM from DI (representing total receipt from DI to date of over $10MM under the previously disclosed +$25MM DROSRITE™ contract to deliver five (5) 5,000 TPY DROSRITE™ Systems, plus two (2) 10,000 TPY DROSRITE™ Systems).

About PyroGenesis Canada Inc

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com , or at www.otcmarkets.com . Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws . Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

Tags: , , , , , , , ,
Posted in All Recent Posts, Featured, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Receives Confirmation that the first 5,000 TPY DROSRITE System Successfully Passes Factory Acceptance Test $RTN $NOC $UTX $DDD.ca $HPQ.ca

$HPQ.ca Partner #Apollon Solar Delivers First Batch of Carbon Coated Nano Silicon Powders to INRS for Evaluation $EFL.ca $EGT.ca $ENPH $PYR.ca

Posted by AGORACOM-JC at 10:05 AM on Thursday, November 19th, 2020

Advances Its Silicon Materials for Batteries Development Program

  • Apollon Solar produces first batch of carbon coated nano silicon powders.
  • HPQ Silicon is developing a portfolio of silicon–based products using proprietary innovative low cost and scalable processes. The target objective is to produce high value speciality Silicon products needed by batteries and electric vehicle manufactures.

MONTREAL, Nov. 19, 2020 – Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or “the Company”) ( TSX-V: HPQ ; FWB: UGE ; Other OTC : URAGF ), is pleased to announce that, in addition to manufacturing samples of porous Silicon nanopowders of different sizes (2 nm to 1 µm) and pore structures (Microporous (<5nm), Mesoporous (5nm – 50nm) or Macroporous (>50nm)), HPQ Silicon R&D consortium member Apollon Solar of France has also commenced evaluation of different carbon encapsulating processes for Silicon nanopowders. As part of this HPQ – led effort, Apollon has delivered a first batch of carbon coated nano silicon powders to Professor Lionel Roué team at the Institut National de la Recherche Scientifique (INRS) for evaluation. Other batches of silicon materials (coated and non-coated) are being prepared and will be sent the INRS for evaluations over the coming weeks.

ACCELERATING R&D ON NANO SILICON POWDERS CARBON COATING

Apollon proposed that in addition to carbon coating their porous Silicon nanopowders they could use commercially available but expensive (US$ 22,500 per Kg) 1 nano silicon powders to evaluate the efficiency of different carbon coating processes. Using powders with the same characteristic as the powders to be produced by HPQ NANO PUREVAP™ N ANO S ILICON R EACTOR should reduce our R&D timeline and give us valuable insight moving forward.

“ Producing carbon coated nano silicon powders for testing this early in the process is another demonstration of the depth and flexibility of HPQ’s R&D consortium. HPQ is committed to staying at the forefront of Silicon for batteries R&D . This latest effort is part of our plan to produce products for renewable energy storage participants and electric vehicle manufacturers who continue to search for cost effective ways of increasing the Silicon contained in their batteries. ,” said Bernard Tourillon, President and CEO HPQ Silicon. “Silicon’s potential to meet energy storage demand is undeniable , generating massive investments , and serious industry interest. We are very confident that demand for the Silicon materials we will produce , with our low-cost scalable process es , will be high demand by batteries and EV manufacturers in this renewable energy revolution . ”

SILICON POTENTIAL FOR BATTERY ANODE MATERIAL BECOMES MAINSTREAM

Tesla’s latest battery day presentation confirmed that the future of battery anodes will include Silicon. Tesla’s “… plans on removing graphite from the anode … ” 2 , points to the need for innovative silicon solutions which HPQ is focused on, to make Silicon – based anodes technically and economically feasible for the production of more efficient rechargeable Li-batteries.

Presently, Silicon is used in a blended form with graphite and typically only represents around 5% by wt , which explains the limited performance improvements achieved to date. The primary hurdle to increasing Silicon anode content in Li-ion batteries is the mitigation of Silicon swelling and cracking during the lithiation phase 3 in order to achieve a cycling stability comparable to graphite.

Ongoing R&D indicates that the two most promising avenues for resolving these issues are:

  1. Nanosizing Silicon powders to eliminate cracking during the lithiation phase.
  2. Encapsulating the Silicon in order to improve its swelling and cracking characteristics.

HPQ is in the forefront of addressing these issues with the PUREVAP™ NSiR process and our ongoing work on porous silicon nanopowders and carbon coating nano silicon.

About HPQ Silicon

HPQ Silicon Resources Inc. ( TSX-V: HPQ ) is a Canadian Innovative Silicon Solutions Provider.

Silicon (Si), also known as silicon metal, is one of today’s key strategic materials needed for the decarbonization of the economy and the Renewable Energy Revolution (“RER”).

Silicon is the most abundant element in earth’s crust but does not exist in its pure state and must be extracted from quartz (SiO 2 ) in what has historically been a capital and energy intensive process. HPQ is building a portfolio of silicon–based products using innovative scalable processes. The target objective is to produce high value speciality Silicon products using technologies that will reduce energy consumption, GHG’s, and carbon footprint.

Working with PyroGenesis Canada Inc. (TSX-V: PYR) , a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAP™ “Quartz Reduction Reactors” (QRR) , an innovative process (patent pending), which will permit the one step transformation of quartz (SiO 2 ) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential ;

     • HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • Through its 100% owned subsidiary HPQ NANO Silicon Powders Inc, the PUREVAP™ Nano Silicon Reactor (NSiR ) , a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires.

    •  HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries .

    •     During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP™ SiNR .

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders.

    •  The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.

    •  Develop the hydrogen generation potential of Silicon nanopowders for use with the Gennao™ system.

    •  Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the Gennao™ H 2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).

This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Tags: , , , , , , , , , , ,
Posted in Featured, HPQ-Silicon Resources Inc. | Comments Off on $HPQ.ca Partner #Apollon Solar Delivers First Batch of Carbon Coated Nano Silicon Powders to INRS for Evaluation $EFL.ca $EGT.ca $ENPH $PYR.ca

Peak $PKK.ca $PKKFF Expands New Financing Program, Adds 2nd Distributor with Over 250K Retail Clients $ALY.ca $DELX.ca $MOS.ca $MOGO.ca CTZ.ca $TRAD.ca

Posted by AGORACOM-JC at 7:43 AM on Thursday, November 19th, 2020
Peak Fintech Group (@PEAK_Fintech) | Twitter
  • Announced that it has signed an agreement with packaged foods wholesale distributor Beijing Jingying Corporate Management Ltd. to bring Peak’s Cubeler Lending Hub financing solution to BJM and its more than 250,000 retail clients
  • Peak launched a financing program powered by Lending Hub in October specifically designed to provide better cash flow flexibility to large wholesale distributors and their retail clients
  • The program, which recorded its first transactions a week ago, allows for retailers to have up to 90% of the price of the products they purchase from participating distributors financed by the Lending Hub’s banks and lending institution

Montreal, Quebec–(November 19, 2020) – Peak Positioning Technologies Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that it has signed an agreement with packaged foods wholesale distributor Beijing Jingying Corporate Management Ltd. (“BJM”) to bring Peak’s Cubeler Lending Hub financing solution to BJM and its more than 250,000 retail clients.

Peak launched a financing program powered by Lending Hub in October specifically designed to provide better cash flow flexibility to large wholesale distributors and their retail clients. The program, which recorded its first transactions a week ago, allows for retailers to have up to 90% of the price of the products they purchase from participating distributors financed by the Lending Hub’s banks and lending institutions.

BJM is the second wholesale distributor to subscribe to the program joining consumer electronics product distributor Beijing Dianjing Company Ltd., which helped launch the program with its 60,000 plus online retail clients. BJM is a major distributor of a variety of popular products from China Oil and Foodstuffs Corporation (COFCO), for which it has exclusive distribution rights to approximately 200,000 Petro-China convenience stores and on online retail giant JD.com. COFCO is a state-owner food processing company. It’s China’s largest food processor, manufacturer and commodities trader. With operations in Japan, the US, the UK, Australia and Canada, it’s one of the largest agribusiness groups in all of Asia.

Most recently BJM became an authorized distributor of RELX brand e-cigarettes, one of China’s most popular and fastest growing brands of e-cigarettes, sold at over 3,000 retail outlets throughout the country.

“We are very pleased to be joining this wonderful financing program created by Peak,” commented Mr. Yang Zhang, CEO of BJM. “We have no doubt that this will be extremely beneficial to most of our clients and we very much look forward to getting them signed up as quickly as possible,” he went on to say.

“I would like to take this opportunity to welcome Mr. Zhang and BJM to our new Lending Hub financing program and look forward to working with him and his team,” said Peak Group China CEO, Mr. Liang Qiu. “BJM’s arrival to the program brings us a great mixture of online and offline stores and allows us to further showcase Lending Hub’s versatility when it comes to its ability to help businesses up and down the supply chain whether they operate predominantly online or offline. We’ve noticed somewhat of a blurring of the online and offline retail space lately including JD.com announcing plans for a network of 5 million brick-and-mortar stores in the next 3 years. I think with Lending Hub’s ability to process and analyze data coming from its member businesses both online and offline, Peak is ideally positioned to play an increasingly important role in this blurring or evolution of the retail space,” concluded Mr. Qiu.

Wall Street Reporter’s NEXT SUPER STOCK Livestream – November 19, 2020

Peak will be a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK livestream conference on Thursday November 19, 2020 at 12:30pm EST. CEO Johnson Joseph will discuss the addition of BJM to Peak’s new financing program, the potential annual revenue it could bring and answer investor audience questions. Those interested can click the following link to register and join the livestream: Next Super Stock Livestream Registration

About Peak Positioning Technologies Inc.:

Peak Positioning Technologies Inc. is the parent company of a group of innovative financial technology (Fintech) subsidiaries operating in China’s commercial lending industry. Peak’s subsidiaries use technology, analytics and artificial intelligence to create an ecosystem of lenders, borrowers and other participants in China’s commercial lending space where lending operations are conducted rapidly, safely, efficiently and with the utmost transparency. For more information: http://www.peakpositioning.com.

For more information, please contact:

CHF Capital Markets
Cathy Hume, CEO
416-868-1079 ext.: 251
[email protected]

Peak Positioning Technologies Inc.
Johnson Joseph, President and CEO
514-340-7775 ext.: 501
[email protected]

Twitter: @peakfintech
Facebook: @peakfintech
LinkedIn: Peak Positioning
YouTube: Peak Positioning

Forward-Looking Statements / Information:

This news release may include certain forward-looking information, including statements relating to business and operating strategies, plans and prospects for revenue growth, using words including “anticipate”, “believe”, “could”, “expect”, “intend”, “may”, “plan”, “potential”, “project”, “seek”, “should”, “will”, “would” and similar expressions, which are intended to identify a number of these forward-looking statements. Forward-looking information reflects current views with respect to current events and is not a guarantee of future performance and is subject to risks, uncertainties and assumptions. The Company undertakes no obligation to publicly update or review any forward-looking information contained in this news release, except as may be required by applicable laws, rules and regulations. Readers are urged to consider these factors carefully in evaluating any forward-looking information.

Tags: , , , , , , , , , , , ,
Posted in Featured, Peak Fintech Group | Comments Off on Peak $PKK.ca $PKKFF Expands New Financing Program, Adds 2nd Distributor with Over 250K Retail Clients $ALY.ca $DELX.ca $MOS.ca $MOGO.ca CTZ.ca $TRAD.ca

Loop Insights $MTRX.ca $RACMF Partners With iSTOC, Europe’s Leading Covid-19 Mobile Testing Applications Company, to Create Global FDA and HIPPAA Compliant Covid Tracing and Testing Solution $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:15 AM on Thursday, November 19th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the signing of a referral and partnership agreement with iSTOC Ltd. of Finland to provide a complete end-to-end integrated COVID-19 management platform consisting of rapid mobile testing, integrated lab results, and venue tracing with real-time, automated exposure alert notification capabilities.
  • The combined solution arising from this partnership will create a Covid-19 tracing and testing solution that is FDA and HIPPAA compliant and can be deployed by any government, NGO, healthcare organization or enterprise-level organization worldwide.

VANCOUVER, British Columbia, Nov. 19, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to announce the signing of a referral and partnership agreement with iSTOC Ltd. of Finland to provide a complete end-to-end integrated COVID-19 management platform consisting of rapid mobile testing, integrated lab results, and venue tracing with real-time, automated exposure alert notification capabilities.

The combined solution arising from this partnership will create a Covid-19 tracing and testing solution that is FDA and HIPPAA compliant and can be deployed by any government, NGO, healthcare organization or enterprise-level organization worldwide.

Loop Insights CEO Rob Anson stated : “I am very honoured for the opportunity to partner with Jarmo and his world-class team at iSTOC. These have been very trying times, and as we head into the fall-winter months, every country is in desperate need of a complete transformative solution that enables the resumption of in-person schooling, travel, commerce, and a return of spectators to live events. This is a very big day for the Company as our partnership with iSTOC positions us as a true global leader regarding complete Covid-19 management solutions.”

iSTOC WILL HAVE FACILITATED MILLIONS OF TESTS IN AT LEAST 50 COUNTRIES BY 2020 END
iSTOC has developed a disruptive mobile solution called IDA (immediate diagnostics and analytics) and has launched rapid tests that can detect antibodies for different infectious diseases from a small drop of blood, plus a mobile diagnostics solution for analyzing the test results, as well as, geographical mapping capabilities for the spread of infectious diseases such as Covid-19. The globally scalable end-to-end solution has proven to be a powerful product and service, offering significant and innovative new business opportunities for iSTOC business partners and customers.

The IDA Platform digitalizes and analyses lateral flow tests (LFTs), including all major infectious diseases. Unlike PCR tests, LFTs detect the antibodies for diseases like Covid-19, which means that LFTs do not show early acute infections but can detect infections beyond the first 14 days of the infection, after which PCR is ineffective.

All diagnostics are performed using smartphone cameras, making it possible to deliver on three important diagnostic criteria: high quality, accessibility even in the most remote locations, and affordability in countries with lower income and high out of pocket costs.

iSTOC has facilitated millions of tests in over 25 countries and expects to be present in at least twice as many countries by the end of 2020.

LOOP AND iSTOC DELIVER FDA AND HIPPAA COMPLIANT INTEGRATED COVID-19 MANAGEMENT SOLUTION

The companies have partnered to deliver a fully compliant solution with both FDA and European regulations and is also HIPAA compliant. Loop’s AI-powered data platform and iSTOC’s front end testing application will integrate to deliver a turn-key end-to-end Covid-19 management solution.

Leveraging Loop’s Anonymized Digital ID and Digital Wallet Application and iSTOC’s leading testing and mobile telemedicine application, the combined solution will provide a complete product offering with safety and data security protecting all personally identifiable information. iSTOC’s real-time dashboard decisioning leverages “big data” to enable comprehensive review and ensure safer environments such as venues and workplaces.

PARTNERSHIP PROVIDES LOOP THE ABILITY TO ADDRESS GLOBAL OPPORTUNITIES
On October 29th, Loop Insights and Amazon Web Services (AWS) hosted a webinar to showcase the Company’s Venue Tracing Solution to a global audience of hospitality businesses that resulted in 1,000 attendees from industries including but not limited to:

  • Hotels
  • Airlines
  • Venue Owners
  • Sports & Entertainment Organizations

The Company has been engaged in several discussions with global hospitality companies in search of a solution to enable the safe resumption of their operations and ensure their long-term viability and sustainability.

As a result of the partnership with iSTOC, Loop Insights now can offer rapid test and lab results to any organization searching for a complete end-to-end Covid-19 solution across Europe and dozens of other countries where iSTOC has existing adoption and service contracts. The combined product offering featuring Loop’s end-to-end solution will focus on large scale government opportunities, hospitals, stadiums, long-term care facilities, construction sites, HR administration, campuses, airlines, cruise ships, resorts, and government and corporate buildings that need to safely reopen and resume operations.

iSTOC’s CEO, Jarmo Järvenpää stated, “Loop Insights’ venue tracing platform is the perfect complement to our best-in-class immediate diagnostics and analytics of infectious disease application. For the first time, a combined product and service offering will enable a complete end to end management solution.”

LOOP IN DISCUSSIONS WITH CRUISE INDUSTRY AS CARNIVAL POSTS $3 BILLION QUARTERLY LOSS DUE TO COVID-19

According to Guardian.com, Carnival reported a $3B quarterly loss due to the Covid-19 pandemic. With airlines as the first industry adopting rapid testing to reduce or eliminate the need for 14-day quarantine periods, the cruise industry is looking to embrace and adopt technologies that can allow them to safely reopen with contact tracing and best of breed protocols and processes for contactless solutions in order for their economic recovery to begin. To date, Loop has been actively involved in many conversations with not only airports and airlines but the cruise industry as well. The Company believes as a result of the partnership with iSTOC, the Company is well-positioned to deliver the complete end to end solution to enable the cruise industry to reopen its operations and instill confidence in travellers safely.

This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights

About iSTOC:
iSTOC is a Finland-based health-tech company that operates globally and is a preferred vendor for several health organizations. iSTOC integrates Point of Care diagnostics, machine vision, mobile technology and cloud computing into one reliable platform. iSTOC has developed a disruptive mobile solution IDA (immediate diagnostics and analytics). The end-to end solution has proven to be a powerful product and service, offering significant and innovative new business opportunities for iSTOC partners and customers around the world. iSTOC IDA Platform digitalizes and analyses lateral flow tests (LFT), including all major infectious diseases as well as blood typing, female and reproductive health and drugs of abuse. More information about iSTOC in the company webpage https://istoc.io /

About Loop Insights :
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.

For more information, please contact: 
Loop Insights Inc.LOOP Website : www.loopinsights.ai 
Rob Anson, CEOFacebook: @ LoopInsights 
T : +1 877-754-5336 Ext. 4Twitter: @ LoopInsights 
E : [email protected]LinkedIn: @ LoopInsights 

Forward-Looking Statements/Information:  

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , , , , , , , , ,
Posted in Featured, Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca $RACMF Partners With iSTOC, Europe’s Leading Covid-19 Mobile Testing Applications Company, to Create Global FDA and HIPPAA Compliant Covid Tracing and Testing Solution $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Empower Clinics $CBDT.ca $EPWCF Kai Medical Lab to Introduce New Influenza A/B COVID RT-PCR Test to Differentiate Influenza From COVID-19. Recent $1,000,000 Testing Order Tt Utilize New Protocol the Kai ABC RT-PCR Test $WELL.ca $DOC.ca $DOCRF $VMD.ca $VPT.ca $ADK.ca

Posted by AGORACOM-JC at 7:07 AM on Thursday, November 19th, 2020
  • Announced that Kai Medical Laboratory (“KAI”) will be introducing its new KAI ABC RT-PCR test protocol to differentiate between Influenza A/B and COVID-19 (“ABC”), which will be vital in the diagnosis and treatment of respiratory pathogens
  • The new KAI ABC RT-PCR test protocol is expected to be ready for the market in the first week of December, in time for the most recent 9,000 unit, $1,000,000 order for a film & television production

VANCOUVER BC / November 19, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company serving a database of 165,000 patients through clinics in the southwest United States, a telemedicine platform and medical diagnostics laboratory, is pleased to announce that Kai Medical Laboratory (“KAI”) will be introducing its new KAI ABC RT-PCR test protocol to differentiate between Influenza A/B and COVID-19 (“ABC”), which will be vital in the diagnosis and treatment of respiratory pathogens.

The new KAI ABC RT-PCR test protocol is expected to be ready for the market in the first week of December, in time for the most recent 9,000 unit, $1,000,000 order for a film & television production.

Empower Clinics Chairman and CEO, Steven McAuley, stated “Kai Medical Laboratory with its team of scientists and lab experts are opening new channels of expansion for Empower in research and diagnostics, enabling the company to access dramatically larger national and international markets for healthcare products. We have a number of exciting developments coming that expand and diversify our reach both through the lab and within our clinic layer that have direct access to patients”

MULTIPLE BENEFITS OF KAI ABC RT-PCR RANGE FROM EARLY AND CORRECT DIAGNOISIS TO PACKAGED COST SAVINGS

COVID-19 and influenza viruses have a similar disease presentation. They both cause respiratory disease, which presents as a wide range of illness from asymptomatic or mild through to severe disease and death. As such, the benefits of this KAI ABC RT-PCR test protocol being able to differentiate between the Flu and COVID-19 are invaluable as follows:

First, it is vital in the diagnosis and treatment of respiratory pathogens. As most COVID-19 testing now primarily focuses on COVID-19 only, diagnosing the difference between the two will be crucial to treatment, health outcomes, and overall health of the population. Specifically, differentiating the pathogens will help medical professionals quickly diagnose and treat more efficiently & efficaciously.

Second, it is a vital tool in helping slow down the spread of COVID-19. Specifically, the speed of transmission is an important point of difference between the two viruses. Influenza has a shorter median incubation period (the time from infection to appearance of symptoms) than COVID-19. Transmission in the first 3-5 days of illness is a major driver for the spread of viral infections. This makes COVID-19 extremely difficult to contain. This is why testing to differentiate the viral infections becomes critical to “slowing the spread.”

Finally, affordability and efficiency. Though the overall cost of an ABC RT-PCR test is approximately 15% to 25% more expensive than an RT-PCR test, providing analysis on all three viruses is significantly cheaper and more affordable than testing for them separately. Moreover, from an efficiency point of view, simultaneously confirming a patient has the flu and does not have COVID-19 from the same collected specimen, allows them, their families and work colleagues to return to a normal life much faster.

BENEFITS TO EMPOWER CLINICS

From a business development point of view, Empower has a high degree of confidence the multiple benefits listed above will translate into significant new business, as evidenced already by the transition of the Company’s recent $1,000,000 test order by a film & tv production from RT-PCR to the new KAI ABC RT-PCR protocol.

“From an R&D perspective, Kai Medical Laboratory is focused on the future and new innovative quality testing to better understand the epidemiology and contagion containment that we have all experienced during this pandemic.” said Yoshi Tyler, President Kai Medical Laboratory. She further states “Kai Medical will continue to be at the forefront of science and innovative quality care by providing value added services, accuracy, and consistency. As such, we believe this will be the first of many successful R&D product announcements in the near future.”

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER

Empower is creating a network of physicians and practitioners who integrate to serve patient needs, in-clinic, through telemedicine, and with decentralized mobile delivery. A simplified, streamlined care model bringing key attributes of the healthcare supply chain together, always focused on patient experience. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative in the United States. Empower recently acquired Kai Medical Laboratory, LLC as a wholly owned subsidiary with large-scale testing capability.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Dustin Klein
Director
[email protected]
720-352-1398

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the fact that Kai Medical Laboratory will complete the development of ABC RT-PCR test; the development of new accounts using the new test; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley’s franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Tags: , , , , , , ,
Posted in All Recent Posts, Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca $EPWCF Kai Medical Lab to Introduce New Influenza A/B COVID RT-PCR Test to Differentiate Influenza From COVID-19. Recent $1,000,000 Testing Order Tt Utilize New Protocol the Kai ABC RT-PCR Test $WELL.ca $DOC.ca $DOCRF $VMD.ca $VPT.ca $ADK.ca

TransCanna $TCAN.ca Closes 1st Tranche of Unit Financing $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 7:30 PM on Wednesday, November 18th, 2020
tcan-square
  • Announced that it has closed the 1st tranche of a Unit financing. In connection with the closing, the Company issued 1,838,000 Units at a price of $0.55 per Unit, for gross proceeds of $1,010,900.
  • Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance.

Vancouver, British Columbia–(November 18, 2020) –  TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce that it has closed the 1st tranche of a Unit financing. In connection with the closing, the Company issued 1,838,000 Units at a price of $0.55 per Unit, for gross proceeds of $1,010,900. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE or such other stock exchange the Company’s shares may be trading on is equal to or greater than $1.25 for a period of 20 consecutive trading days. 63,040 Broker’s warrants were issued in connection with finder’s fees payable and in lieu of 8% cash finder’s fees, 63,040 Broker’s Units were issued.

The private placement is subject to the approval of the Canadian Securities Exchange (“CSE”) and the securities will be subject to a four-month hold period under securities laws. The Company intends to use the net proceeds from the private placement for working capital purposes.

The Company did not file a material change report more than 21 days before the expected closing of the private placement as the details of the private placement and the participation therein by related parties of the company were not settled until shortly prior to closing and the company wished to close on an expedited basis for sound business reasons and in a time frame consistent with usual market practices for transactions of this nature.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , , , ,
Posted in TransCanna Holdings Inc. | Comments Off on TransCanna $TCAN.ca Closes 1st Tranche of Unit Financing $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

PyroGenesis $PYR.ca Receives Final Approval to Graduate to the Toronto Stock Exchange $RTN $NOC $UTX $DDD.ca $HPQ.ca

Posted by AGORACOM-JC at 6:09 PM on Wednesday, November 18th, 2020
  • Announced that it has received final approval from the Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (“TSXV”) and list its common shares (“Common Shares”) on the TSX
  • Company’s Common Shares will be listed for trading on the TSX at the opening of markets on Friday, November 20, 2020 under its current trading symbol “PYR”
  • In connection with the listing of the Common Shares on the TSX, the last day of trading on the TSXV will be Thursday, November 19, 2020

MONTREAL, Nov. 18, 2020 — PyroGenesis Canada Inc. ( http://www.pyrogenesis.com ) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce that it has received final approval from the Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (“TSXV”) and list its common shares (“Common Shares”) on the TSX.

The Company’s Common Shares will be listed for trading on the TSX at the opening of markets on Friday, November 20, 2020 under its current trading symbol “PYR”. In connection with the listing of the Common Shares on the TSX, the last day of trading on the TSXV will be Thursday, November 19, 2020 and the Common Shares will be delisted from the TSXV effective as of the commencement of trading on the TSX. Shareholders will not be required to take any action in connection with the graduation and listing on the TSX.

“It is indeed a pleasure to be able to announce today that PyroGenesis is uplisting to the most senior exchange in Canada, the TSX, this Friday. We are very pleased to announce this significant achievement for PyroGenesis that confirms our development and growth as a company. I want to take this opportunity to thank the team at PyroGenesis, as well as the professionals who guided us; particularly our legal advisors,” said Mr. Peter Pascali, CEO and Chair of PyroGenesis. “We also would like to thank the TSXV for providing us with the platform to grow into the Company we are today, and attract a solid stable of investors. It is important to recognize that a platform, be it the TSXV or the TSX, is only part of the equation. The PyroGenesis team, technologies, as well as the solid base of business, and business relationships we have developed, while on the TSXV, are well suited for this graduation.”

“We look forward to this uplisting and the additional credibility that the Company will gain by trading on the most significant stock exchange in Canada, which is also one of the largest in North America 1 ,” added Ms. Rodayna Kafal, VP IR & Comms. and Director of PyroGenesis. “We anticipate that this step change will provide PyroGenesis with greater visibility in the marketplace and access to a broader and more diverse range of international and institutional investors.”

About PyroGenesis Canada Inc

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com . Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws . Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release .

SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: http://www.pyrogenesis.com/

Tags: , , , , , , , , ,
Posted in All Recent Posts, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Receives Final Approval to Graduate to the Toronto Stock Exchange $RTN $NOC $UTX $DDD.ca $HPQ.ca

VIDEO – ThreeD Capital $IDK.ca $IDKFF Discusses Big Picture, Some Portfolio Investments, Favourite Sectors … And Why 2021 Is “The Year To Be All In” $PKK.ca $PKKFF $MTRX.ca $RACMF

Posted by AGORACOM-JC at 5:04 PM on Wednesday, November 18th, 2020
IDK-square-for-blog

ThreeD Capital (IDK:CSE / IDKFF:OTCQB) prides itself on discovering great companies before everyone else … and it casts a wide net to find the best of the best ranging from precious metals companies to completely disruptive companies.  Moreover, IDK isn’t afraid to invest and be patient in both public and private companies.  

As such, it’s like and ETF for ground floor investments that small cap investors would either be unable to find (private) or unable to participate in (early round accredited investors)  

It is able to do all this and do it well under the leadership of one of the greatest investors in Canadian history – Sheldon Inwentash, the Founder, Chairman and CEO of IDK. Inwentash’s track record of success speaks for itself, including successful exits in the hundreds of millions and even billions in previous years.  His last company commanded a market cap north of $1 Billion and now he’s looking to create another success out of IDK.    

Will he do it?  He’s off to a good start so far by quietly making investments over the past couple of years that are now starting to pay off.  In this interview Inwentash discusses:

  • His investment philosophy
  • A couple of his recent investments in Peak Fintech (PKK:CSE) and Loop Insights (MTRX:TSXV)
  • Why he’s investing heavily in gold juniors
  • Why he’s investing heavily in blockchain companies + their tokens

Best of all, after one hell of a ride for the financial markets in 2020, Inwentash talks about why 2021 “is the year to be all in”  

Watch this great interview … because when a legendary financier speaks, every small cap investor should be listening.

Tags: , , , , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, ThreeD, ThreeD Capital | Comments Off on VIDEO – ThreeD Capital $IDK.ca $IDKFF Discusses Big Picture, Some Portfolio Investments, Favourite Sectors … And Why 2021 Is “The Year To Be All In” $PKK.ca $PKKFF $MTRX.ca $RACMF

CLIENT FEATURE: Avicanna $AVCN.ca $AVCNF A Revenue Generating, Canadian Vertically – Integrated Biopharmaceutical Company $WEED.ca $TLRY $HARV.ca

Posted by AGORACOM-JC at 12:39 PM on Wednesday, November 18th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Avicanna (AVCN: TSX) (AVCN: OTCQX) (0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.

Third Quarter Highlights

  • $882K in revenue, an increase of 24% from Q2-2020,
  • Double-digit growth quarter over quarter from Q4-2019
  • Reached a major milestone with the launch of certain products from its RHO Phyto product line in Canada and further diversified its revenue streams.

When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:

1.  The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year. 

2.  Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain. In addition, the company recently received certification and authorization for the sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia. 

3.  Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.

AND… if that is not enough …

4.  Avicanna’s Colombian cultivation division hosts 500,000 Sq ft of low cost and USDA certified organic Cannabis Cultivation. The company recently Made History As The First Ever Export Of Feminized Hemp Seeds From Colombia To The United States. 7,000,000 Seeds For $380,000, with an additional 75,000,000 Seeds Available For Export In Several Pending Transactions.

Hub On AGORACOM / Corporate Profile

Tags: , , , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts | Comments Off on CLIENT FEATURE: Avicanna $AVCN.ca $AVCNF A Revenue Generating, Canadian Vertically – Integrated Biopharmaceutical Company $WEED.ca $TLRY $HARV.ca

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Provides BioCloud Update and Enters into Distribution Agreements $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 8:14 AM on Wednesday, November 18th, 2020
kontrol-logo

Safe Space Technology™

  • Company intends to sell BioCloud directly to various potential customers. At the same time the Company is pursuing both exclusive and non-exclusive distribution channels for BioCloud sales
  • Entered into two non-exclusive BioCloud distribution agreements
  • Distribution agreements cover Ontario and Saskatchewan
  • Kontrol Energy Corp. is in the process of changing its name to Kontrol Technologies Inc.
  • The name change is anticipated to take place by the end of December 2020
  • As of November 17, 2020, the Company has $3.8 Million of cash on hand

TORONTO, ON / November 18, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to provide an update on its BioCloud technology development.

“Our team continues to execute on the vision to create and bring to market a safe space technology,” says Paul Ghezzi, CEO of Kontrol.

Distribution Agreements

The Company intends to sell BioCloud directly to various potential customers. At the same time the Company is pursuing both exclusive and non-exclusive distribution channels for BioCloud sales. Kontrol is pleased to announce it has entered into two non-exclusive BioCloud distribution agreements. The distribution agreements cover Ontario and Saskatchewan.

The Company has also entered into discussions with various parties for potential industry exclusive distribution agreements which would require minimum unit quantity orders.

New Website

Kontrol has launched a new website for BioCloud. For more information please visit www.kontrolbiocloud.com.

Name Change

Kontrol Energy Corp. is in the process of changing its name to Kontrol Technologies Inc. The name change is anticipated to take place by the end of December 2020.

Cash on Hand

As of November 17, 2020, the Company has $3.8 Million of cash on hand.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others

BioCloud is not a medical device and the Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE:KNR)(OTCQB: KNRLF)(FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.


Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.


For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

Tags: , , , , , , , , , ,
Posted in All Recent Posts, Featured, Kontrol Energy Corp. | Comments Off on Kontrol $KNR $KNR.ca $KNR.c $KNRLF Provides BioCloud Update and Enters into Distribution Agreements $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

« Older Entries
Newer Entries »